Jana Partners’s Pfizer PFE Stock Holding History

Jana Partners’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-263,500	Closed	-$7.42M	–	79
2014 Q2	$7.42M	Buy	+263,500	New	+$7.51M	0.05%	48

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Jana Partners's PFE Position: Q2 2016 in Review

Jana Partners sold out of Pfizer (PFE) in Q2 2016, closing a stake of 14,187,160 shares — an estimated $399M sold.

Jana Partners first reported a position in PFE in Q4 2015 and held it in 2 quarters. The position peaked at $399M in Q1 2016. 1,993 funds tracked by Wall St. Rank hold PFE as of Q2 2016.

Jana Partners reported no remaining Pfizer position as of Q2 2016 after selling out during the quarter.
Jana Partners sold 14,187,160 Pfizer shares in Q2 2016, an estimated $399M.
Jana Partners first reported a position in Pfizer in Q4 2015 and held it in 2 quarters.
Jana Partners's Pfizer position peaked at $399M in Q1 2016.
1,993 funds tracked by Wall St. Rank held Pfizer as of Q2 2016.

Based on Jana Partners's 13F filing for Q2 2016, filed 15 Aug 2016.